(4-Chlorophenyl)(cyclopropyl)methanamine hydrochloride, 95+%, 25g

1-Cyanoadamantane>98.0%(GC)1g

1-Pyridin-2-yl-piperidine-4-carboxylic acid, 98.0%, 250mg

3'-Aminoacetophenone, 99.00%, 25g

8-chloro-2-(3-methylphenyl)quinoline-4-carboxylic acid, 95.0%, 1g

2-Iodosobenzoic Acid>98.0%(T)1g

7-AMINOQUINOLINE-2-CARBOXYLIC ACID, 95.0%, 250mg

1-(4-Fluorobenzyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 1g

1-Bromo-4-fluoro-3-methyl-2-nitrobenzene, 95.0%, 10g

5-Chlorothiophene-3-carboxylic acid, 95.0%, 10g

5-Bromo-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95.0%, 5g

3-Fluoro-4-(trifluoromethyl)benzonitrile>99.0%(GC)1g

Plan PLPH S100x/1.25 phase contrast objective